Short-course versus long-course antibiotics in prosthetic joint infections: a systematic review and meta-analysis of one randomized controlled trial plus nine observational studies.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 02 09 2018
revised: 19 03 2019
accepted: 26 03 2019
pubmed: 6 5 2019
medline: 18 8 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Prosthetic joint infections (PJIs) often require long-course antibiotic therapy. However, recent studies argue against the current practice and raise concerns such as the development of antibiotic resistance, side effects of medications and medical costs. To review and compare the outcomes of short-course and long-course antibiotics in PJIs. We conducted a systemic review and meta-analysis using a predefined search term in PubMed and EMBASE databases. Studies that met the inclusion criteria from inception to June 2018 were included. The quality of the included studies was assessed. A total of 10 articles and 856 patients were analysed, comprising 9 observational studies and 1 randomized controlled trial. Our meta-analysis showed no significant difference between short-course and long-course antibiotics (relative risk = 0.87, 95% CI = 0.62-1.22). Additionally, the older the studied group was, the more short-course antibiotics were favoured. When treating PJI patients following debridement, antibiotics and implant retention, an 8 week course of antibiotic therapy for total hip arthroplasty and a 75 day course for total knee arthroplasty may be a safe approach. For two-stage exchange, a shorter duration of antibiotic treatment during implant-free periods is also generally safe with the usage of antibiotic-loaded cement spacers.

Sections du résumé

BACKGROUND
Prosthetic joint infections (PJIs) often require long-course antibiotic therapy. However, recent studies argue against the current practice and raise concerns such as the development of antibiotic resistance, side effects of medications and medical costs.
OBJECTIVES
To review and compare the outcomes of short-course and long-course antibiotics in PJIs.
METHODS
We conducted a systemic review and meta-analysis using a predefined search term in PubMed and EMBASE databases. Studies that met the inclusion criteria from inception to June 2018 were included. The quality of the included studies was assessed.
RESULTS
A total of 10 articles and 856 patients were analysed, comprising 9 observational studies and 1 randomized controlled trial. Our meta-analysis showed no significant difference between short-course and long-course antibiotics (relative risk = 0.87, 95% CI = 0.62-1.22). Additionally, the older the studied group was, the more short-course antibiotics were favoured.
CONCLUSIONS
When treating PJI patients following debridement, antibiotics and implant retention, an 8 week course of antibiotic therapy for total hip arthroplasty and a 75 day course for total knee arthroplasty may be a safe approach. For two-stage exchange, a shorter duration of antibiotic treatment during implant-free periods is also generally safe with the usage of antibiotic-loaded cement spacers.

Identifiants

pubmed: 31050758
pii: 5485291
doi: 10.1093/jac/dkz166
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2507-2516

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Hung-Teng Yen (HT)

School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Ronan W Hsieh (RW)

Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA.

Chung-Yen Huang (CY)

School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Tzu-Chun Hsu (TC)

Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Timothy Yeh (T)

Department of Molecular and Cellular Biology, University of California, Davis, CA, USA.

Yee-Chun Chen (YC)

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Wen-Shan Chen (WS)

Department of Dermatology, Taichung Veterans General Hospital, Taichung, Taiwan.

Chien-Chang Lee (CC)

Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH